Zenas BioPharma, Inc. (ZBIO): Insider Trading, Congress Trades & Research | Tormere

ZBIO

$27.30+0.22%visit website download financials (.py)

Zenas BioPharma, Inc.

Market Cap

$1.7B

Live price × shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.89

24mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

1723.4

Price / TTM revenue

P/B

7.0

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Enavate Sciences GP, LLC · 2026-08-19

Analyst Consensus

Strong Buy

14 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-18	2026-05-18	MOULDER LEON O JR	Director & Chief Executive Officer	Purchase	60.0K	$16.88	$1.01M	96.9K	View
2026-04-29	2026-04-29	MOULDER LEON O JR	Director & Chief Executive Officer	Purchase	35.0K	$17.62	$617K	1.79M	View
2026-04-28	2026-04-29	MOULDER LEON O JR	Director & Chief Executive Officer	Purchase	25.0K	$18.02	$451K	1.75M	View
2026-03-31	2026-04-02	Lu Hongbo	Director	Purchase	78.8K	$19.93	$1.57M	426.7K	View
2026-03-31	2026-04-01	Fairmount Funds Management LLC	Director	Purchase	150.0K	$20.00	$3.00M	2.36M	View

1–5 of 21

1 / 5

Recent News

Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript

SeekingAlpha · 2026-10-27

ZBIO Nov 2026 22.500 put (ZBIO261120P00022500) stock historical prices and data

Yahoo Finance UK · 2026-10-26

ZBIO261120P00022500 Interactive Stock Chart | ZBIO Nov 2026 22.500 put Stock

Yahoo Finance · 2026-10-26

ZBIO Nov 2026 22.500 put (ZBIO261120P00022500) stock price, news, quote and history

Yahoo Finance UK · 2026-10-26

Zenas BioPharma, Inc. Estimates – NASDAQ:ZBIO

TradingView · 2026-10-24

Wall Street Analysts Predict a 77.61% Upside in Zenas BioPharma, Inc. (ZBIO): Here's What You Should Know

Yahoo · 2026-10-23

ZBIO Nov 2026 30.000 call (ZBIO261120C00030000) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-10-23

Zenas BioPharma Stock Gains Attention After Long Term Trial Data

Yahoo · 2026-10-21

Zenas BioPharma (ZBIO) Is Down 5.1% After New Phase 3 Obexelimab IgG4-RD Data Release

Yahoo · 2026-10-13

HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $44 Price Target

Benzinga · 2026-10-13

Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease

Yahoo · 2026-10-12

Zenas BioPharma Presents New Obexelimab Data In Immunoglobulin G4-Related Disease At 6th International Symposium On IgG4-Related Disease

Benzinga · 2026-10-12

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Yahoo · 2026-10-07

Zenas BioPharma to Host Virtual R&D Event

Yahoo · 2026-10-06

Zenas BioPharma: Obexelimab Is Being Graded On The Wrong Curve (NASDAQ:ZBIO)

Seeking Alpha · 2026-10-05

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-05-18	MOULDER LEON O JR	P	60,000	$1M
2026-04-29	MOULDER LEON O JR	P	35,000	$616,700
2026-04-28	MOULDER LEON O JR	P	25,000	$450,500
2026-03-31	Lu Hongbo	P	3,768	$70,197.84
2026-03-31	Fairmount Funds Management LLC	P	150,000	$3M